ROSENWALD LINDSAY A MD
4, 1997-11-10
Previous: CLINICOR INC, DEF 14A, 1997-11-10
Next: MARTIN INDUSTRIES INC /DE/, 10-Q, 1997-11-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Rosenwald, Lindsay A.
   c/o Paramount Capital Asset Management, Inc.
   787 Seventh Avenue, 48th Flr.
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Xenometrix, Inc. (XENO)

3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   10/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   (X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>                         |
                           |      |    | |                  |   |           |                   |      |                           |
                           |      |    | |                  |   |           |                   |      |                           |

___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- - -----------------------------------------------------------------------------------------------------------------------------------|
Warrants              |$2.14816|10/07|O(1)| |83,332     |   |10/07|10/07  |Common Stock|83,332 |Attach-|397,881 (2) |D  |          |
                      |        |/97  |    | |           |   |/97  |/02    |            |       |ment A |            |   |          |
Warrants              |$2.14816|10/30|O(1)| |83,333     |   |10/30|10/30  |Common Stock|83,333 |Attach-|397,881 (2) |D  |          |
                      |        |/97  |    | |           |   |97   |02     |            |       |ment A |            |   |          |
- - -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:

(1) The  warrants  were issued to the Aries  Fund,  a Cayman  Island  Trust (the
"Trust") and the Aries Domestic Fund, L.P. (the "Partnership",  and collectively
with the Trust,  the "Aries Funds") in  consideration  for the Issuer's  drawing
down  $250,000 on each of October 7, 1997 and October 30,  1997,  from a Line of
Credit that was extended to the Issuer on September 25, 1997 by the Aries Funds.

(2) Includes  108,332  warrants to purchase shares of common stock of the Issuer
held by the Trust;  58,333  warrants to purchase  shares of common  stock of the
Issuer held by the Partnership; 8,818 options to purchase shares of common stock
of the Issuer that were extended to Dr. Rosenwald in his capacity as a member of
the Board of  Directors  of the Issuer;  25,733  warrants to purchase  shares of
common  stock of the  Issuer  held by  Paramount  Capital,  Inc.,  of which  Dr.
Rosenwald is the President and sole  shareholder;  12,000  warrants owned by the
Partnership  that were acquired in the open market and 18,000  warrants owned by
the Trust that were acquired in the open market.

SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- - -----------------------------
Lindsay A. Rosenwald, M.D.


DATE
11/10/97

<PAGE>


                                  ATTACHMENT A


                  Reporting Person:         Lindsay A. Rosenwald, M.D.
                  Issuer:                   Xenometrix, Inc. (XENO)

         The warrants  were issued to the Aries Fund, a Cayman Island Trust (the
"Trust") and the Aries Domestic Fund, L.P. (the "Partnership",  and collectively
with the Trust,  the "Aries Funds") in  consideration  for the Issuer's  drawing
down  $250,000 on each of October 7, 1997 and October 30,  1997,  from a Line of
Credit that was extended to the Issuer on September 25, 1997 by the Aries Funds.
Dr. Rosenwald is the president and sole  shareholder of Paramount  Capital Asset
Management,  Inc. ("PCAM"),  the investment manager of the Trust and the general
partner of the Partnership. Dr. Rosenwald and PCAM disclaim beneficial ownership
of the  securities  owned by the  Aries  Funds  except  to the  extent  of their
pecuniary interest therein, if any.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission